Transforming Cancer Care through Precision Oncology
A Time of Hope and Promise
It's been called a glimmer of hope for many cancer patients and their families. The genome. Yet not many people fully understand the complexity of the science and the power it plays in providing the best course of treatment for cancer patients. Due to this exciting, cutting-edge treatment, the Avera McKennan Foundation has begun raising dollars to support precision oncology for patients at the Avera Cancer Institute.
Through generous contributions, grant funding and vital partnerships, Avera Cancer Institute formed the Avera Center for Precision Oncology in 2014 and has gone on to see hundreds of patients since its inception. Current therapies still exist, but with YOUR help, we can reach our goal of treating all cancers with this transformative care.
Kristen Kilmer believes in getting personal, right down to her DNA. When diagnosed with Stage IV breast cancer at the age of 37, this young mother put on her fighting gloves to battle the disease. Thanks to the talented team of researchers at the Avera Cancer Institute Center for Precision Oncology, state-of-the-art personalized medicine was used to determine the best course of treatment based on DNA testing. Today, she is living with NED (no evidence of the disease) and can get back to enjoying life to the fullest. But she remains grateful for her caregivers and the strides taken to treat cancer through genetic testing. This is her story.
The Story Continues
Chris Lawrence truly believes in living one day at a time. Having been diagnosed with an incurable bile duct cancer, he has undergone extensive genomic testing to ease chronic pain. Today, he believes the heart of his story is how the power of Christ has provided hope and healing and that God has obviously used Precision Oncology to help. Read his full story >>
An Age of Hope
Genomics at Avera is a complex science that involves multiple experts locally and across the nation and world. The Avera Center for Precision Oncology team consists of Brian Leyland-Jones, MB BS, PhD, and Casey Williams, PharmD, as well as Avera Cancer Institute physicians, researchers and many others. Watch as Dr. Brian Leyland-Jones explains more about the importance of genetic sequencing and how early intervention leads to the best chance of a cure.
To learn more about the campaign for Precision Oncology, please call the Avera McKennan Foundation at 605-322-8900.